More on The Sun Pharmaceutical RIOMET ER Recall
Recently, Sun Pharmaceutical Industries has announced its voluntary recall of one lot of RIOMET ER (metformin hydrochloride for extended-release oral suspension).
The company issued the recall upon discovering that the medication has a level of N-Nitrosodimethylamine (NDMA). This level is more than the allowable Acceptable Daily Intake (ADI) limit assigned by the Food and Drug Administration.
What is NDMA?
Studies revealed that NDMA is a probable human carcinogen, a substance that could lead to cancer.
As of this time, the company hasn’t received any reports of any issues.
Meanwhile, the recall includes the RIOMET ER™ (metformin hydrochloride for extended-release oral suspension), 500 mg per 5 mL. This product serves as a supplement to diet and exercise. It also aids in improving glycemic control in adults and pediatric patients 10 years of age and older with type 2 diabetes mellitus.
According to reports, RIOMET ER has been distributed nationwide to wholesale customers.
Have you purchased and used RIOMET ER? Did you suffer any symptoms? Let us know about your experience.
What You Need To Do
For patients who were are taking RIOMET ER as part of their medication, kindly contact your pharmacist, physician, or medical provider for consultation concerning alternative treatment.
Meanwhile, consumers who have further questions about this recall can call SUN PHARMA at (800) 818-4555 Monday through Friday from 8:00 am to 5:00 pm (EST) or by email at drug.safetyUSA@sunpharma.com.
Editor’s note on Sun Pharmaceutical’s RIOMET ER Recall:
This piece is to inform you about the recent Sun Pharmaceutical RIOMET ER Recall.
If you are considered eligible to be among the class of consumers described in the article above, you may eventually be able to participate in receiving any compensation the court may award.
We’d be happy to help you take a step in the right direction, fight this issue, and better enable you to join in on any potential consumer class action. If interested, please send an email to Outreach@ConsiderTheConsumer.com, find us on Twitter or Facebook, or even connect with us directly on our website! We look forward to hearing from you all.
Similarly, please check out our current list of Class Actions and Class Action Investigations, here.
Interested in articles like these? Become a subscriber below!